Investing

The growth story remains intact. Multiples remain compressed on a historical basis.

While the S&P 500 is up 14% this year, lately investors have begun to question the health of the bull market.

Gold’s recent correction isn’t the start of a bear market for the yellow metal. Bulls point to more upside ahead.

Nearly 60 million Americans care for an adult with a complex medical condition or disability.

Who pays for what should be clear to everybody before money matters take a toll on the household. Boundaries are important.

It’s been a great year for stocks, but in the past few days the bull market seems to have lost some of its mojo.

Activists also report to the SEC on Neumora Therapeutics, Insight Enterprises, Garrett Motion, and Rogers.

Maybe it was an excuse to take profits. Maybe investors realized that Palantir stock was too expensive at 248 times 12-month forward earnings. It’s time for everything else to shine for a while.

Investors mostly accepted the enormous AI-related capital spending from Big Tech, whose earnings are up 29%, mostly through spending with one another. The rest of the S&P 500 is up 5%.

The sector is cheaper than it was—but only the shares of some companies are worth buying.

The coffee maker is selling a 60% stake in the business to Boyu Capital.

Unpartnered is not synonymous with unprepared, and it most certainly does not mean unsuccessful. It means you’re the architect of your own financial future.

Contingent value rights have become common in biotechnology deals. More than half of all transactions this year include them, according to a Jefferies report in October.

Shares are down 25% since Barron’s recommended them in June.

The canning company’s low valuation, hefty cash flows, and big-name customers could help the shares pop 30%.

Sonu Kalra has built a stellar record as manager of the Fidelity Blue Chip Growth fund. He calls ChatGPT’s 2022 launch AI’s “iPhone moment.”

Berkshire Hathaway is holding a record amount of cash and is a net seller of stocks. Investors may want to reduce risk in their portfolios.

Both Kimberly Clark and Kenvue are Dividend Aristocrats. Dividends after a merger could well disappoint.

When stock prices decline, it is often very profitable to sell puts on stocks you’re willing to own. Here’s how the trade works.

The investment management firm snapped up more than $5.3 million worth of Bullish shares.

Taxes, liquidity, and estate planning are just some of the issues for holders of private company equity.

Activists also report to the SEC on Orthofix Medical, Bristow Group, and Sionna Therapeutics.

Owning top-shelf companies could still make a lot of sense for investors looking for steady performers that can deliver in almost all market conditions. 

Tesla shareholders will vote on Nov. 6 for an unprecedented CEO incentive plan. Here’s what investors should know.

“The forgotten Goliath” of the big banks is serious about shedding its reputation as an underachiever. CEO Brian Moynihan’s future may depend on it.